221 related articles for article (PubMed ID: 8330399)
61. Comparison of five cyclosporin immunoassays with HPLC.
Tredger JM; Roberts N; Sherwood R; Higgins G; Keating J
Clin Chem Lab Med; 2000 Nov; 38(11):1205-7. PubMed ID: 11156361
[TBL] [Abstract][Full Text] [Related]
62. The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.
Huser B; Thiel G; Oberholzer M; Beveridge T; Bianchi L; Mihatsch MJ; Landmann J
Transplantation; 1992 Jul; 54(1):65-9. PubMed ID: 1631947
[TBL] [Abstract][Full Text] [Related]
63. Monitoring cyclosporin in blood: between-assay differences at trough and 2 hours post-dose (C2).
Johnston A; Chusney G; Schütz E; Oellerich M; Lee TD; Holt DW
Ther Drug Monit; 2003 Apr; 25(2):167-73. PubMed ID: 12657910
[TBL] [Abstract][Full Text] [Related]
64. A comparison of EMIT and FPIA methods for the detection of cyclosporin A blood levels: does impaired liver function make a difference?
Witzke O; Heemann U; Thesing A; Wolfhard U; Erhard J; Philipp T; Michel MC
Eur J Clin Pharmacol; 1997; 52(5):413-6. PubMed ID: 9272414
[TBL] [Abstract][Full Text] [Related]
65. Isolation of cross-reacting compounds to Incstar Cyclo-Trac SP RIA in blood samples obtained from cardiac allograft patients on cyclosporine therapy.
Loo JC; Gallicano KD; McGilveray IJ; Beaudoin N; Jindal SL
J Clin Lab Anal; 1991; 5(2):153-5. PubMed ID: 2023061
[TBL] [Abstract][Full Text] [Related]
66. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.
Schütz E; Svinarov D; Shipkova M; Niedmann PD; Armstrong VW; Wieland E; Oellerich M
Clin Chem; 1998 Oct; 44(10):2158-64. PubMed ID: 9761250
[TBL] [Abstract][Full Text] [Related]
67. Comparison of whole-blood cyclosporine levels measured by radioimmunoassay and fluorescence polarization in patients post orthotopic liver transplant.
Hooks MA; Millikan WJ; Henderson JM; Mullins R; Lampasona V
Ther Drug Monit; 1989; 11(3):304-9. PubMed ID: 2658211
[TBL] [Abstract][Full Text] [Related]
68. Effect of assay methodology on pharmacokinetic differences between cyclosporine Neoral and Sandimmune formulations.
Aspeslet LJ; LeGatt DF; Murphy G; Yatscoff RW
Clin Chem; 1997 Jan; 43(1):104-8. PubMed ID: 8990230
[TBL] [Abstract][Full Text] [Related]
69. Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations.
Dailly E; Deslandes G; Hourmant M; Petit T; Renaud C; Treilhaud M; Jolliet P
J Clin Lab Anal; 2008; 22(4):282-5. PubMed ID: 18623123
[TBL] [Abstract][Full Text] [Related]
70. Cyclosporine measurement by FPIA, PC-RIA, and HPLC following liver transplantation.
Burckart GJ; Jain A; Diven W; Venkataramanan R; Starzl TE
Transplant Proc; 1990 Jun; 22(3):1319-22. PubMed ID: 2190393
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of Abbott TDx monoclonal assay of cyclosporine in whole blood.
Moyer TP; Winkels J; Krom R; Wiesner R
Clin Chem; 1991 Jun; 37(6):1120-1. PubMed ID: 2049832
[No Abstract] [Full Text] [Related]
72. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F
Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
[TBL] [Abstract][Full Text] [Related]
73. Relationship between cyclosporine concentrations obtained using the Roche Cobas Integra and Abbott TDx monoclonal immunoassays in pre-dose and two hour post-dose blood samples from kidney transplant recipients.
Garrido MJ; Hermida J; Tutor JC
Ther Drug Monit; 2002 Dec; 24(6):785-8. PubMed ID: 12451297
[TBL] [Abstract][Full Text] [Related]
74. Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassay.
Dusci LJ; Hackett LP; Chiswell GM; Ilett KF
Ther Drug Monit; 1992 Aug; 14(4):327-32. PubMed ID: 1519308
[TBL] [Abstract][Full Text] [Related]
75. 12-hour area under the curve cyclosporine concentrations determined by a validated liquid chromatography-mass spectrometry procedure compared with fluorescence polarization immunoassay reveals sirolimus effect on cyclosporine pharmacokinetics.
Napoli KL
Ther Drug Monit; 2006 Dec; 28(6):726-36. PubMed ID: 17164687
[TBL] [Abstract][Full Text] [Related]
76. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.
Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF
Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473
[No Abstract] [Full Text] [Related]
77. Evaluation of four automated methods for determination of whole blood cyclosporine concentrations.
Hamwi A; Veitl M; Männer G; Ruzicka K; Schweiger C; Szekeres T
Am J Clin Pathol; 1999 Sep; 112(3):358-65. PubMed ID: 10478141
[TBL] [Abstract][Full Text] [Related]
78. [Monitoring of cyclosporin A concentration in whole blood with fluorescence polarization immunoassay after bone marrow transplantation].
Murayama T; Matsushita K; Takahashi T; Matozaki S; Nakagawa T; Isobe T
Rinsho Ketsueki; 1992 Apr; 33(4):413-7. PubMed ID: 1602602
[TBL] [Abstract][Full Text] [Related]
79. Identification and analysis of nine metabolites of cyclosporine in whole blood by liquid chromatography. 2: Comparison of patients' results.
Lensmeyer GL; Wiebe DA; Carlson IH
Clin Chem; 1987 Oct; 33(10):1851-5. PubMed ID: 3311467
[TBL] [Abstract][Full Text] [Related]
80. [The significance and problem of cyclosporine blood level monitoring].
Yuhki Y
Rinsho Byori; 1990 Feb; 38(2):157-62. PubMed ID: 2184276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
